Your session is about to expire
← Back to Search
Telehealth for Lewy Body Dementia
N/A
Recruiting
Led By Bhavana Patel, DO
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial found that delivering care for Lewy body dementia remotely using video technology was effective and improved access to care for patients.
Who is the study for?
This trial is for people with Lewy Body Dementia (LBD), which includes some Parkinson's disease symptoms. Participants need a specialist-confirmed LBD diagnosis, mild to moderate dementia, and internet access with Zoom. They must speak English and have a caregiver at home willing to join the study. Healthcare professionals involved should have over a year of experience with LBD.
What is being tested?
The trial is testing 'Tele-neurohub', a video technology system designed to deliver interdisciplinary care remotely to patients with LBD, aiming to improve their access to specialist care without needing to travel.
What are the potential side effects?
Since this intervention involves telehealth services rather than medication or invasive procedures, side effects are not typical in the medical sense but may include technical difficulties or discomfort using video technology.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Number of completed tele-health visits
Secondary study objectives
Appropriateness assessed by Intervention Appropriateness Measure
Satisfaction assessed by Patient Assessment of Communication of Telehealth questionnaire.
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Tele-neurohubExperimental Treatment1 Intervention
This group will receive the tele-neurohub intervention which includes telemedicine appointments with the neurologist, speech therapist, social worker, and nutritionist at baseline, 3 months and 6 months, and PT and OT every 2 weeks for maintenance neuro-rehabilitation.
Group II: Usual care groupActive Control1 Intervention
Receive usual care but will have study visit assessments at baseline and 6 months.
Find a Location
Who is running the clinical trial?
University of FloridaLead Sponsor
1,409 Previous Clinical Trials
767,117 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,804 Previous Clinical Trials
28,194,793 Total Patients Enrolled
Bhavana Patel, DOPrincipal InvestigatorUniversity of Florida
1 Previous Clinical Trials
60 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have Lewy Body Dementia with mild to moderate severity.
Research Study Groups:
This trial has the following groups:- Group 1: Usual care group
- Group 2: Tele-neurohub
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.